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DUSP3, is a small dual specificity phosphatase of poorly known physiological functions and 52 
for which only few substrates are known. Using DUSP3-deficient mice, we recently reported 53 
that DUSP3 deficiency confers resistance to endotoxin- and polymicrobial-induced septic 54 
shock. We showed that this protection was macrophage-dependent. In this work, we further 55 
investigate the role of DUSP3 in sepsis tolerance and show that the resistance is sex-56 
dependent. Using adoptive transfer experiments and ovariectomized (OVX) mice, we 57 
highlighted the role of female sex hormones in the phenotype. Indeed, in OVX female and 58 
male mice, the dominance of M2-like macrophages observed in DUSP3-/- female mice was 59 
reduced suggesting a role of this cell subset in sepsis tolerance. At the molecular level, 60 
DUSP3 deletion was associated with oestrogen-dependent decreased phosphorylation of 61 
ERK1/2 and Akt in peritoneal macrophages stimulated ex vivo by LPS. Our results 62 
demonstrate that oestrogens may modulate M2-like responses during endotoxemia in a 63 
DUSP3-dependent manner. 64 
 65 
 66 

























     
     
     
     
     
     







Sepsis and septic shock are complex clinical syndromes that arise when the local body 77 
response to pathogens becomes systemic and injures its own tissues and organs (1). When 78 
infection occurs, bacterial components such as LPS, are recognized by the host and 79 
inflammation is initiated. TLR4 pathway is activated and triggers the release of cytokines, 80 
chemokines and nitric oxide (NO) (2, 3). Systemic release of pro-inflammatory cytokines 81 
causes large-scale of cellular and tissue injuries, leading to microvascular disruptions, severe 82 
organ dysfunctions and eventually death (4). Sepsis occurrence and outcome depend on 83 
pathogen characteristics but also on risk factors such as age or sex (1). Indeed, women are 84 
better protected against infection and sepsis compared to men. Women younger than 50 years 85 
show a lower incidence of severe sepsis and a better survival compared to age-matched men. 86 
This may be explained by the influence of female sex hormones on the immune system 87 
responses (5). 88 
 89 
DUSP3, or Vaccinia-H1-related (VHR), is an atypical dual specificity phosphatase of 21kDa. 90 
The phosphatase contains one catalytic domain but lacks a binding domain (6). DUSP3 91 
broader catalytic site allows the protein to dephosphorylate both phospho-Tyr and phospho-92 
Thr residues (7). The MAPK ERK1/2 and JNK were the first reported DUSP3 substrates (8–93 
10). Other substrates such as the EGFR and ErbB2 tyrosine receptors (11) and STAT5 94 
transcription factor (12) were also reported. DUSP3 physiological functions started to be 95 
elucidated thanks to the knockout mouse we have generated. Studies from our laboratory 96 
using DUSP3-/- mice showed that DUSP3 plays an important role in platelets biology, in 97 
monocytes and macrophages and in endothelial cells (13–15). In platelets, DUSP3 plays an 98 


















     
     
     
     
     
     





signalling pathways (14). DUSP3 plays also an important role in endothelial cells and 100 
angiogenesis and seems to act as a pro-angiogenic factor (16). Surprisingly, this function was 101 
not correlated with reduced tumour or metastatic growth. Indeed, in an experimental 102 
metastasis model using Lewis lung carcinoma cells (LLC), we found that DUSP3 plays rather 103 
an anti-tumour role since DUSP3-/- mice were more sensitive to LLC metastatic growth when 104 
compared to WT littermates. This enhanced tumour growth in DUSP3-/- mice was associated 105 
with higher recruitment of M2-like macrophages (Vandereyken et al, under revision). 106 
Previous studies from our laboratory and others showed that DUSP3 was downregulated in 107 
some human cancers and upregulated in others (reviewed in (16, 17)). Further studies are 108 
required to better understand the role of this phosphatase in cancer biology. 109 
DUSP3 plays also an important role in immune cell functions. In T cells, DUSP3 can be 110 
activated by ZAP-70 tyrosine kinase after TCR triggering (18). This activation, through 111 
tyrosine phosphorylation of DUSP3, allows the targeting of the MAPK ERK1/2 and the 112 
activation of its downstream signalling pathway. Moreover, in Jurkat leukemia T cells, 113 
DUSP3 targets ERK and JNK, but not p38. Together, these data suggest that DUSP3 controls 114 
T cell physiological functions at least partially through the MAPKs ERK and JNK (8). In 115 
innate immune cells, we recently showed that DUSP3 is the most highly expressed atypical 116 
DUSP in human monocytes. This was also true in mice (15). These findings suggested to us 117 
that DUSP3 could play an important role in innate immune responses. Indeed, using DUSP3-/- 118 
mice, we found that DUSP3 deletion conferred resistance of female mice to LPS-induced 119 
endotoxemia and to polymicrobial infection-induced septic shock. This protection was 120 
macrophage dependent since a higher percentage of M2-like macrophage subset was found in 121 
DUSP3-/- mice. Moreover, the resistance was also associated with a decreased 122 
phosphorylation of the tyrosine kinases ERK1/2 and a subsequent decrease in TNF-α 123 


















     
     
     
     
     
     





In this study, we report that DUSP3 deletion does not protect male mice from LPS-induced 125 
endotoxemia and CLP-induced septic shock and that this protection was female sex hormones 126 
dependent. Furthermore, we report that sepsis resistance was associated with a higher 127 
percentage of M2-like macrophages in peritoneal cavity of DUSP3-/- female mice but not with 128 
decreased pro-inflammatory cytokines production. We also showed that sepsis resistance in 129 
females, but not in males or in OVX females, was associated with decreased ERK1/2, PI3K 130 




































     
     
     
     
     
     





Material and methods 150 
 151 
Mice and ethic statement 152 
C57BL/6 (CD45.2)-DUSP3-/- mice were generated by homologous recombination as 153 
previously reported (13). These mice were backcrossed with C57BL/6-CD45.2 mice (Charles 154 
River) to generate heterozygotes that were mated to generate DUSP3+/+ and DUSP3-/- 155 
littermate colonies used for experimentation. Age matched male and female DUSP3+/+ and 156 
DUSP3-/- mice were used in all the experiments. Mice were kept in ventilated cages under 12-157 
hours dark/12-hours light cycle in an SPF animal facility and received food and water and 158 
libitum. Health status was evaluated every 3 months and mice were always found free of 159 
specific pathogens. 160 
All mouse experiments and procedures were approved by the animal ethics committees of the 161 
Universities of Ghent and Liege and were carrie  out according to their guidelines. 162 
 163 
Cecal ligation and puncture and in vivo LPS challenge 164 
Cecal ligation and puncture (CLP) was performed as previously described (19). For LPS 165 
challenge, mice were i.p. injected with 6mg/kg of LPS. Body temperature was monitored 166 
using a rectal thermometer at various times after LPS injection and after CLP. Death of mice 167 
was recorded and the data were analysed for statistical significance of differences between the 168 
experimental groups. 169 
 170 
Mice irradiation and bone marrow transplantation 171 
10-12 weeks old C57BL/6 (CD45.2) donor mice were killed by cervical dislocation. Tibiae 172 
and femurs were collected and BM cells were flushed with PBS. BM cells (10x106) were 173 


















     
     
     
     
     
     





recipient mice. 4 weeks later, transplantation efficiency was evaluated on the basis of the ratio 175 
of CD45.2 to CD45.1 cells in the blood of transplanted mice. 176 
 177 
Female ovariectomy and in vivo oestrogen complementation 178 
4 weeks old females were anesthetized using ketamine/xylazine (150 mg/kg and 20 mg/kg). A 179 
vertical incision of 2-3 cm was performed in the middle of the back. 1 cm lateral of the 180 
midline, another incision of 2-3 mm was performed in the fascia. Adipose tissue surrounding 181 
ovary was pulled out and ovary was removed after clamping. The same operation was realized 182 
for contralateral ovary. The incision in fascia was closed with stitches and the skin incision 183 
with clips. Shame operated mice were used as a control. All above procedures were applied to 184 
these mice except the removal of ovaries. For in vivo oestrogen complementation, 2 weeks 185 
after surgery, subcutaneous implants for controlled release of 17β-oestradiol (1.5µg/day) 186 
(Belma technologies) were applied to OVX mice and were kept for 3 weeks before sacrifice.  187 
 188 
Antibodies and reagents 189 
The following materials were from Cell Signalling Technology Inc: anti-phospho-Akt 190 
(Ser473), anti-Akt, anti-phospho-ERK1/2 (Thr202/Tyr204), anti-ERK, anti-phospho-PI3K 191 
p85 (Tyr458)/p55 (Tyr199), anti-PI3K p85, anti-phospho-GSK3α/β (Ser21/9). Anti-GSK3α/β 192 
was from Santa Cruz. Anti-GAPDH antibody was from Sigma. HRP-conjugated anti-goat 193 
antibody was from Dako. HRP-conjugated anti-mouse antibody was from GE healthcare. 194 
HRP-conjugated anti-rabbit antibody was from Merck Millipore. APC-anti-CD45.1 (A20) and 195 
PerCp-Cy5.5-anti-CD45.2 (104), FITC-anti-CD11b, APC-Cy7-anti-Ly6G, PE-anti-CD3, 196 
PerCp-anti-CD8, FITC-anti-CD4, Biotin-anti-B220 and streptavidin-PE-Cy7 were all from 197 


















     
     
     
     
     
     





were from eBiosciences. PE-Cy-anti-Ly6G antibody was from BioLegend. LPS from 199 
Escherichia coli serotype O111:B4 was from Sigma and was diluted in pyrogen-free PBS. 200 
 201 
Animal blood sampling and plasma preparation 202 
Peripheral blood was drawn in EDTA-coated tubes (BD Microtainer K2E tubes; BD 203 
Biosciences) by puncturing the heart with 26G needle. Centrifugation was performed twice at 204 
800g for 15 min at RT. Plasma samples were separated in sterile Eppendorf tubes, aliquoted 205 
in small volumes, and stored at -80°C until used.  206 
 207 
Meso Scale Discovery electrochemiluminescence assay 208 
MSD assay was performed according to manufacturer’s instructions (Mesoscale Discovery). 209 
Briefly, plasma was diluted 15 and 15.000 times for TNF and IL-6 respectively. For IL-10 210 
and IFN-γ, samples were diluted twice. Samples were loaded on 96 well plates, incubated 2h 211 
at RT and washed. Detection antibodies were added for 2h at RT. Signal detection was 212 
measured within 15 minutes after read buffer addition using MSD instrument. 213 
 214 
Isolation and stimulation of thioglycollate elicited peritoneal macrophages 215 
Peritoneal washes were performed 4 days after intraperiteonal injection of 1 mL of 4% 216 
thioglycollate broth (Sigma). 5 mL of PBS-EDTA 0.6 mM were injected twice in the 217 
peritoneal cavity using an 18G needle and then collected. Peritoneal macrophages were 218 
selected by adherence to tissue culture plastic dishes in complete RPMI 1640 medium. 219 
Peritoneal macrophages were stimulated with LPS 1µg/mL during 15, 30 or 60 minutes or 220 
during 8 and 24h hours, depending on the experiment performed 221 
 222 


















     
     
     
     
     
     





Peritoneal washes were centrifuged 10 min at 350g and the pellet was re-suspended in PBS. 224 
For surface cell staining, cells were incubated for 15 min with anti-CD16/CD32 (Fcγ III/IIR) 225 
before labelling for 30 min with specific antibodies for 30 min at 4°C. Cells were then washed 226 
and fixed with 1% paraformaldehyde solution. Cells were next analysed on FACSCanto II 227 
(Becton Dickson) using FlowJo (Tree Star). 228 
 229 
Protein extraction and Western blot  230 
For Western blot experiments, cells were stimulated for the indicated time points and lysis 231 
was performed with RIPA buffer (50 mM Tris-HCl (pH = 8.0), 150 mM NaCl, 1% NP-40, 232 
0.5% sodium deoxycholate, 0.1% SDS, 1 mM orthovanadate, complete protease inhibitor 233 
cocktail tablets EDTA free and 1 mM phenylmethylsulfonyl fluoride) on ice during 20 min. 234 
Lysates were next clarified by centrifugation at 19.000g during 20 min at 4°C. The resulting 235 
supernatants were collected and protein concentrations were determined using the 236 
colorimetric Bradford reagent (Bio-Rad). Proteins were next denatured at 95°C in Laemmli 237 
buffer (40% glycerol; 8% SDS 5%; 20% B-mercaptoethanol; 20% Tris-HCl 0.5 M pH6.8; 238 
0.05% bromophenol blue and water) during 5 min.  239 
Denatured samples were run on 10% SDS-PAGE gel and transferred onto nitrocellulose 240 
membranes. To block the non-specific binding sites, membranes were incubated for one hour 241 
at room temperature in Tris-buffered saline-Tween 20 containing 5% of non-fat milk or 3% 242 
BSA (bovine serum albumin). Membranes were incubated overnight with primary antibody at 243 
4°C. Membranes were next washed thrice in Tris-buffered saline-Tween and incubated with 244 
HRP-conjugated secondary antibody during one hour at room temperature. The blots were 245 
developed by enhanced chemiluminescence (ECL kit, Amersham) according to the 246 



















     
     
     
     
     
     





RNA puriﬁcation, reverse transcription, and real-time PCR 249 
RNA was extracted from PMs using the miRNeasy Mini Kit (Qiagen) and cDNA was 250 
synthesized using Expand reverse transcriptase (Roche) according to the recommendations of 251 
the manufacturer. cDNA was ampliﬁed using Sybr Green PCR Master Mix (Roche) and 0.3 252 
mM speciﬁc primers for Arginase 1 (Arg1), iNOS, and E2-microglobulin (E2M). All 253 
quantitative PCR were performed on a LightCycler System for RealTime PCR (Roche). The 254 
ratio between the expression level of the gene of interest and b2M in the sample was deﬁned 255 
as the normalization factor. Relative mRNA quantities for Arg1 and iNOS were determined 256 
using the ΔCq method. All primers were from Eurogentec. Sequences were as follow: 257 
inducible NO synthase (iNOS): FW, 59-GCTTCTGGTCGATGTCATGAG-39, RV, 59-258 
TCCACCAGGAGATGTTGAAC-39; Arg1: FW, 59-CAGAAGAATGGAAGAGTCAG-39, 259 
RV, 59-AGATATGCAGGGAGTCACC-39; and b2M: FW, 59-260 
CACCCCACTGAGACTGATACA-39, RV, 59-TGATGCTTGATCACATGTCTCG-3. 261 
 262 
Statistical analysis 263 
The student t-test was used to assess statistical differences between different groups. Survival 264 
differences after LPS challenge and CLP were analysed by Kaplan-Meier analysis with log 265 
rank test. Results were considered as significant if p-value < 0.05. Results are presented as 266 
mean ± SEM. Prism software (GraphPad) was used to perform statistical analysis. 267 
* = p < 0.05, ** = p < 0.01, *** = p < 0.001. 268 
 269 


















     
     
     
     
     
     







DUSP3-/- female, but not male, mice are resistant to LPS-induced endotoxemia and to CLP-273 
induced septic shock 274 
In a previous study, we showed that DUSP3 deletion protected mice from LPS-induced 275 
endotoxemia and polymicrobial infection-induced septic shock (15). Only female were used 276 
in the first study. To investigate whether the protection observed is a general feather of 277 
DUSP3 deletion or sex dependent, we challenged DUSP3-/- males with a lethal dose of LPS 278 
(i.p. injection of 6 mg/kg) and compared their survival to females and to WT control 279 
littermates of both sex. Body temperature was also monitored. As expected and previously 280 
reported, 90% of DUSP3-/- female mice were resistant to LPS while only 5% of DUSP3+/+ 281 
female mice survived the challenge (15). Interestingly, DUSP3+/+ and DUSP3-/- male mice 282 
were equally sensitive to LPS-induced death (Fig. 1A). Body temperature of all groups of 283 
mice, but not DUSP3-/- females, decreased after LPS injection. 24h later, almost all DUSP3-/- 284 
females recovered while the other groups remained hypothermic (Fig. 1B). These results were 285 
further confirmed in the cecal ligation and puncture (CLP) model performed on DUSP3+/+ and 286 
DUSP3-/- males and females. As expected, only 10% of DUSP3+/+ and DUSP3-/- male mice 287 
and DUSP3+/+ female mice were still alive by the end of the experiment whereas 70% of 288 
DUSP3-/- female mice survived (Fig. 1C.). The body temperature of each group dropped after 289 
surgery and only DUSP3-/- female mice recovered (Fig. 1D). These results indicate a sex 290 
specific response to septic shock in DUSP3-/- mice. 291 
 292 
Ovariectomized DUSP3-/- mice are sensitive to LPS-induced death 293 
Male and female sex hormones receptors have been identified on immune cells suggesting 294 


















     
     
     
     
     
     





been recognized to influence numerous immune pathophysiological processes (21). To 296 
elucidate the effect of female sex hormones, we ovariectomized (OVX) 4 weeks old 297 
DUSP3+/+ and DUSP3-/- mice (OVX mice). As controls, another group of 4 weeks old 298 
DUSP3+/+ and DUSP3-/- were sham operated. To assess the ovariectomy’s efficiency, we 299 
checked the presence and the size of the uterus. Successful OVX mice were deprived of 300 
normal uterus development whereas sham operated mice presented a normally developed 301 
uterus (Fig. 1E). 6 weeks after surgery, sham and OVX mice were challenge with 6 mg/kg of 302 
LPS and survival and temperature were monitored (Fig. 1F and 1G). Ovariectomy impaired 303 
the observed endotoxemia resistance of DUSP3-/- mice, whereas sham operated DUSP3-/- 304 
mice were still fully protected from endotoxin-induced death. These data demonstrate that 305 
female sex hormones are involved in the observed resistance of DUSP3-/- female mice to LPS-306 
induced lethality. 307 
 308 
DUSP3-/- female bone marrow cells rescue DUSP3+/+ female, but not male mice from LPS-309 
induced lethality 310 
We previously showed that adoptive transfer of DUSP3-/- female bone marrow cells or 311 
monocytes to DUSP3+/+ female mice was sufficient to transfer resistance to LPS-induced 312 
lethality (15). We therefore investigated whether this is also true when recipient mice are 313 
males. To generate chimeric mice, 10x106 bone marrow cells (BM) from DUSP3-/- C57BL/6-314 
CD45.2 female mice were intravenously injected into lethally irradiated DUSP3+/+ C57BL/6-315 
CD45.1 recipient male and female mice (DUSP3-/- > M-DUSP3+/+ and DUSP3-/- > F-316 
DUSP+/+, respectively). As a control, DUSP3+/+ females BMs were transplanted into lethally 317 
irradiated DUSP3+/+ male or female mice (DUSP3+/+ > M-DUSP3+/+ and DUSP3+/+ > F-318 
DUSP3+/+, respectively). Successful hemato-lymphoid reconstitution was verified by flow 319 


















     
     
     
     
     
     





positive (Fig. 1H and 1I). Moreover, in recipient mice, the expression of DUSP3 in peritoneal 321 
macrophages was abolished in the recipient mice transplanted with DUSP3-/- BM cell 322 
suspension, as showed by DUSP3 immunoblotting (Fig. 1J). 4 weeks after BM 323 
transplantation, 6 mg/kg of LPS were i.p. injected into recipient mice and survival was 324 
monitored during 8 days (Fig. 1K). Interestingly, more than 70% of the chimeric DUSP3-/- > 325 
F-DUSP+/+ mice survived up to the end of the experiment compared to 9% of DUSP3+/+ > F-326 
DUSP3+/+ mice. On the other hand, all DUSP3-/- > M-DUSP3+/+ and DUSP3+/+ > M-327 
DUSP3+/+ mice died within 4 days after LPS injection (Fig. 1K). These data suggest that, in 328 
the absence of DUSP3, both female sex hormones and myeloid cells are required for 329 
resistance to LPS shock. 330 
 331 
DUSP3-deletion-induced LPS shock resistance in female mice, but not in male, OVX and wild 332 
type mice, is associated with increased M2-like macrophages in the peritoneal cavity. 333 
We have previously reported that DUSP3 is expressed in several immune cells where it plays 334 
an important role in macrophage and in T cell functions (15)(18). Since sepsis involves the 335 
participation of both innate and adaptive immune cells (22), we investigated whether DUSP3 336 
deletion-associated survival to shock, in females, was linked to unbalanced contribution of 337 
one cell type or another in LPS-resistant compared to LPS-sensitive mice. We found that, at 338 
basal levels as well as after LPS injection, percentage of CD19posB, CD4posT, CD8posT, 339 
macrophages (Ly6GnegCD11bposF4/80pos), Neutrophils (F4/80neg/CD11bposLy6Gpos), NK 340 
(CD3negNK1.1pos) and NKT (CD3posNK1.1pos) cells were equal between males and females of 341 
both genotypes (Fig. 2A). LPS injection induced a significant reduction of T cells and 342 
macrophages, increased neutrophils infiltration on the peritoneal cavity and had no significant 343 


















     
     
     
     
     
     





We previously reported that increased survival of DUSP3-/- female mice after LPS and CLP 345 
was associated with a higher percentage of M2-like macrophages in the peritoneal cavity of 346 
these mice compared to DUSP3+/+ females (15). To investigate if this is associated to DUSP3-347 
deficient female survival, we phenotyped DUSP3+/+ and DUSP3-/- peritoneal macrophages 348 
from male and female mice (both sham operated and OVX) challenged with LPS based on the 349 
characterisation previously reported by Ghosn et al (23). M1 macrophages are 350 
F4/80intCD11bintLy6Gneg, whereas M2-like macrophages are F4/80hiCD11bhiLy6Gneg (Fig. 2B 351 
and 2C). We confirmed previous findings showing that the percentage of M2-like 352 
macrophages was higher in the peritoneal cavity of DUSP3-/- female mice compared to 353 
littermate controls 2h and 24h after LPS injection (Fig. 2B and 2C). Interestingly, we 354 
observed that the percentage of M2-like macrophages in male mice was slightly lower 355 
compared to DUSP3-/- female mice 2h after LPS challenge. This difference was exacerbated 356 
at 24h after LPS injection. There was not significant difference for the percentage of M2-like 357 
macrophages between DUSP3+/+ and DUSP3-/- male mice. Similarly, there was no difference 358 
in the percentage of M1-like macrophages at 2h and 24h after LPS injection between 359 
DUSP3+/+ and DUSP3-/- female mice. However we noticed a slight increase in the percentage 360 
of M1-like macrophages in males compared to female mice 2h after LPS injection. This 361 
difference was accentuated, though not significantly, at 24h (Fig. 2B and 2C). For the OVX 362 
mice, 2h after LPS injection, the percentage of M1-like macrophages (F4/80intCD11bint) was 363 
higher in DUSP3+/+ and DUSP3-/- OVX mice compared to DUSP3-/- sham mice. The 364 
difference was maintained at 24h, although not significantly (Fig. 2B and 2C). M2-like 365 
macrophages percentage was equal in DUSP3+/+ and DUSP3-/- OVX mice compared to 366 
DUSP3+/+ and DUSP3-/- sham mice 2h after LPS injection. However 24h after LPS challenge, 367 
the percentage of M2-like macrophages in the peritoneal cavity of OVX mice decreased, but 368 


















     
     
     
     
     
     





2C). These data suggest that M2-like macrophages could be involved in the resistance to LPS-370 
induced endotoxemia. To further characterise these cells, we measured the relative expression 371 
of genes associated with M1-like and M2-like PMs, namely, Nos2 and Arg1. At basal levels, 372 
none of the transcript was detected (data not shown). 2h after LPS challenge, Arg1 expression 373 
increased significantly in DUSP3-/- sham compared to DUSP3+/+ sham (Fig. 2D). In males and 374 
OVX groups, Arg1 was detected but at significantly lower levels compared to sham operated 375 
female mice. 24h after LPS injection, level of Arg1 increased dramatically in DUSP3-/- sham 376 
group compared to all the other groups (Fig. 2D). Nos2 levels were low 2h after LPS injection 377 
but increased significantly 22h later in sham operated female mice of both genotypes, though, 378 
the increase was more significant in DUSP3+/+ female mice (Fig. 2D). Altogether, these data 379 
suggest that M2-like macrophages and female hormones could be involved in DUSP3-380 
induced resistance to LPS-induced endotoxemia. 381 
 382 
DUSP3-KO female mice survival to LPS is not due to a modification in pro-inflammatory 383 
cytokines production 384 
We previously reported that DUSP3-/- female survival to LPS was associated with decreased 385 
systemic TNF level compared to DUSP3+/+ mice (15). Therefore, we wanted to know whether 386 
the susceptibility of DUSP3-/- male and OVX mice to LPS-induced death could be linked to 387 
differential expression of TNF or to other pro-inflammatory cytokines such as IL6, IFNJ and 388 
IL10. We measured and compared plasma levels of these four cytokines at basal levels, at 2h 389 
and 24h after LPS challenge in all group of mice, using MSD assay. For TNF, there was no 390 
difference between DUSP3+/+ and DUSP3-/- males. However and as previously reported (15) 391 
there was a significant decrease of this cytokine in DUPS3-/- females compared to DUSP3+/+ 392 
female mice 2h and 24h after LPS challenge (Fig. 3A). Compared to DUSP3+/+ mice, DUSP3-393 


















     
     
     
     
     
     





3B). These differences were maintained in OVX mice groups (Fig. 3A and 3B). For IFNJ, 395 
secretion was equal in all groups of mice 2h after LPS challenge. However, at 24h after LPS 396 
injection, IFNJ levels were lower in DUSP3-/- females sham and OVX compared to DUSP3+/+ 397 
females sham and OVX. There was however, a 10-fold decrease of IFNJ in all OVX mice, 398 
regardless of their genotype. In males, the level of IFNJ was significantly higher in DUSP3-/- 399 
than in the littermates controls at 24h but not at 2h after LPS injection (Fig. 3C). Finally, the 400 
level of IL10 was lower in DUSP3-/- mice compared to controls regardless of sex or type of 401 
surgery (Fig. 3D). Altogether, these data strongly suggest that DUSP3 deletion-induced 402 
female mice resistance to LPS-induced shock is not a consequence of the observed 403 
modifications of the measured cytokines.  404 
 405 
DUSP3-deletion alters ERK1/2 and PI3K/Akt phosphorylation magnitudes and kinetics in 406 
oestrogen-depend manner. 407 
We have previously reported that, although DUSP3 is ubiquitously expressed protein, the 408 
level of expression vary significantly between cell types (15)(14) and during cell cycle 409 
progression (24). We therefore investigated whether its expression vary between males and 410 
females and if it changes in response to LPS or after ovariectomy. As shown in figure 5A, 411 
DUSP3 expression level was similar in males and females and was not influenced by LPS or 412 
OVX (Fig. 5A). 413 
We have previously reported that DUSP3 deletion in female mice macrophages was 414 
associated with decreased ERK1/2 phosphorylation levels after ex vivo LPS stimulation (15). 415 
To investigate if this alteration was also associated with the sex-specific resistance to septic 416 
choc, DUSP3+/+ and DUSP3-/- peritoneal macrophages from sham or OVX mice were 417 
stimulated ex vivo with LPS (1 μg/mL) at different time points and cell lysates were probed 418 


















     
     
     
     
     
     





significantly lower in DUSP3-/- sham peritoneal macrophages at all time points compared to 420 
DUSP3+/+ macrophages. Interestingly, in OVX mice, LPS stimulation led to an equal ERK1/2 421 
activation in both DUSP3-/- and DUSP3+/+ peritoneal macrophages as demonstrated by the 422 
observed phosphorylation levels. There was no difference of ERK1/2 phosphorylation in male 423 
mice from both genotypes (Fig. 4B and 4C).  424 
The observed reduced phosphorylation of ERK1/2 in DUSP3-/- sham mice suggests that 425 
DUSP3 could be targeting either ERK1/2 upstream kinase or one of ERK1/2 phosphatases. 426 
Therefore we analysed MAPKK MEK1/2 activation following ex vivo LPS stimulation (1 427 
μg/mL) of peritoneal macrophages. MEK1/2 kinetic phosphorylation was equal between 428 
DUSP3+/+ and DUSP3-/- sham mice of both sex (Fig. 4D and 4E), suggesting that MEK1/2 is 429 
not targeted by DUSP3.   430 
 431 
The PI3K/Akt pathway is another important pathway activated after TLR4 triggering (25). 432 
We therefore investigated whether DUSP3 deletion could impact this pathway after activation 433 
with LPS and whether the kinetic and magnitude of this activation could be sex dependent. 434 
PI3K and Akt activations were evaluated using phospho-specific antibodies and Western blot 435 
after ex vivo LPS stimulation (1 μg/mL) of peritoneal macrophages at different time points. 436 
Interestingly, PI3K and Akt activations decreased in DUSP3-/- sham peritoneal macrophages 437 
compared to DUSP3+/+ peritoneal macrophages at all time points. This difference was 438 
abolished in OVX mice since the phosphorylation level of PI3K and Akt remained equal 439 
between DUSP3+/+ and DUSP3-/- peritoneal macrophages. The activation of GSK3 440 
downstream target of Akt was, however, not affected by DUSP3 deficiency neither in sham 441 
nor OVX mice (Fig. 5A and 5B). There was no difference in PI3K and Akt activations in 442 


















     
     
     
     
     
     





all time points in DUSP3+/+ and DUSP3-/- LPS- stimulated peritoneal macrophages. GSK3 444 
activation was not affected by DUSP3 deficiency (Fig. 5A and 5B).  445 
These data suggest that DUSP3 affects ERK1/2, PI3K and Akt activation probably in concert 446 
with estrogens. To investigate this hypothesis, DUSP3-/- and DUSP3+/+ female mice were 447 
ovarictomized at the age of 4 weeks. 2 weeks later, half of the mice from each group were 448 
complemented with estrogen using subcutaneous implant for controlled release of 17β-449 
oestradiol (1.5µg/day). Mice were kept for 3 weeks before sacrifice. Peritoneal macrophages 450 
were stimulated ex vivo with LPS (1 μg/mL) at different time points and cell lysates were 451 
probed with anti-phospho-ERK1/2, anti-ERK, anti-phospho-PI3K, anti-PI3K, anti-phospho-452 
Akt and anti-Akt antibodies. As shown in figure 6, oestrogen complementation reduced 453 
significantly the phosphorylation levels of ERK1/2 and Akt in DUSP3-/-, but not in DUSP3+/+, 454 
peritoneal macrophages (Fig.6A and 6B). These data clearly suggest that DUSP3-dependent 455 























     
     
     
     
     
     






It is well recognized that immune responses to infection are sex dependent. Indeed stronger 463 
immune responses confer to women protection against infections and sepsis (26). Several 464 
epidemiological studies have been performed and showed a greater incidence of sepsis in 465 
males compared to females (27). Consequently, compared to males, there are less female 466 
hospitalizations associated with infections. In addition, male sex, and presence of 467 
comorbidities were commonly reported independent predictors of post-acute mortality in 468 
sepsis survivors (28). Interestingly, many of the differences between males and females in 469 
response to infections become apparent at puberty (29). In line with this, women younger than 470 
50 years show lower incidence of severe sepsis and better survival compared to age-matched 471 
men (30). Altogether, these observations suggest a role for sexual hormones in the protection 472 
from severe infections and sepsis. This hypothesis has been supported by the finding that 473 
receptors for reproductive hormones are present in a variety of immune cell types (31). On the 474 
other hand, estrogen have been demonstrated to increase resistance to several bacterial 475 
infections whereas the removal of endogenous estrogens have been shown, for example, to 476 
markedly increase the severity of Mycobacterium avium infections, an effect that can be 477 
reversed after 17E-estradiol replacement (32, 33). The role of female reproductive hormones 478 
in susceptibility to acute infection and sepsis is still however poorly understood.  479 
In the present study, we report that DUSP3 deletion confers resistance to LPS-induced 480 
lethality and to polymicrobial-induced septic shock in female mice but not in males. We 481 
demonstrated that this protection is female sexual hormone and monocyte/macrophage 482 
dependent. Indeed, ovariectomy induced a loss of resistance. On the other hand, DUSP3-/- 483 
monocytes transfer to WT females was sufficient to transfer the resistance to WT recipient 484 


















     
     
     
     
     
     





by our previous study (15). To our knowledge, this is the first report demonstrating a 486 
signalling molecule-induced synergistic immunoprotective effect of monocytes/macrophages 487 
and female sexual hormones against sepsis.  488 
The observed resistance to LPS-induced septic shock of DUSP3-/- female mice was associated 489 
with a modest increase of M2-like macrophages in the peritoneal cavity of mice. This 490 
observation was strengthened by the increase of Arg1 gene expression in DUSP3-/- females 491 
but not in males or ovarictomized mice. Arg1 is indeed a known marker for M2-like 492 
macrophages (34). DUSP3-deficient mice ovariectomy induced a loss of resistance to LPS-493 
induced death with no difference in M2-like macrophage percentage between control groups 494 
and OVX-DUSP3-/- mice. Together with the fact that the percentage of M2-like macrophages 495 
was also equal in both DUSP3+/+ and DUSP3-/- male mice, it suggests that female sex 496 
hormones may influence macrophage alternative activation. Our observations are in line with 497 
studies showing that oestrogens influence numerous immunological processes, among which 498 
monocytes and macrophages physiological functions (35). Indeed, ovarian sex hormones 499 
modulate monocyte adhesion and chemotaxis, TLR expression, cytokines production as well 500 
as phagocytosis activity (36). Moreover several evidences suggest that oestrogens also 501 
influence macrophage polarization. ER-α knockout mice undergo a decrease of alternative 502 
activated macrophages (36). ER-α-deficient macrophages are indeed refractory to IL-4-503 
induced alternative activation as demonstrated by a decrease of IL-4R and STAT6 504 
phosphorylation in these cells (37). Oestrogens have also been reported to increase the 505 
expression of the transcription factor IRF4 (interferon regulatory factor-4) involved in 506 
alternative activation of macrophages (38). Using transcriptomic assay, we did not observe 507 
differences in IL4, IL4R or IRF4 expression levels between DUSP3-KO males and females 508 
neither at basal levels nor after LPS challenge (data not shown). On the other hand, TNF 509 


















     
     
     
     
     
     





DUSP3-/- mice did not influence the level of this pro-inflammatory cytokine, although mice 511 
succumb to endotoxemia. These data were rather surprising since sex steroids are known to 512 
regulate pro- and anti-inflammatory cytokine levels released by macrophages. On the other 513 
hand, female sex hormones are known to negatively regulate TNF production (39), one of the 514 
most important cytokines in sepsis (40, 41). The change of TNF production, as well as the 515 
observed change in IFNJ, IL6, IL-10 and perhaps other cytokines upon DUSP3 deletion 516 
should be therefore considered as an independent phenomenon not related to DUSP3-/- female 517 
mice survival to sepsis.  518 
How does DUSP3 regulate macrophage alternative activation in a female sexual hormone 519 
dependent manner is a complex question to answer. The mol cular mechanisms involved are 520 
probably linked to the observed decrease of ERK1/2 and Akt/PI3K activations. Upon ex vivo 521 
LPS stimulation, DUSP3-/- female peritoneal macrophages showed reduced phosphorylation 522 
of both ERK1/2 and Akt when compared DUSP3+/+ female macrophages. These differences 523 
were not observed in macrophages from OVX DUSP3-/- mice but were maintained in DUSP3-524 
/- OVX mice under oestrogen complementation. Together, these data suggest that, under 525 
inflammatory conditions, oestrogen controls macrophage polarization through DUSP3-526 
ERK1/2-Akt signalling pathway axis.  527 
ERK1/2 has been previously reported to play a role in macrophage polarization through 528 
mTOR signalling pathway (42). Indeed, ERK1/2 phosphorylates and dissociates the tuberous 529 
sclerosis protein (TSC) complex leading to its inactivation and subsequent activation of 530 
mTOR (42), constitutive activation of which leads to decreased IL-4-induced M2 polarization 531 
in TSC-deficient mice (42)(43). The role of sex hormones has not been investigated in these 532 
studies. In our model, it would be interesting to investigate whether the observed lower 533 


















     
     
     
     
     
     





TCS activation and consequently to M2 polarization. On the other hand, it has been reported 535 
that, upon TLR4 stimulation, PI3K engagement is followed by Akt and mTORC1 activation 536 
due to TSC inactivation by Akt (44). This may lead to M1 macrophages polarization (44)(45). 537 
Similarly to ERK decreased phosphorylation, decreased PI3K/Akt activation may lead to TSC 538 
activation and shifts macrophage polarization towards a M2 phenotype. 539 
Another important question raised by our study is how does DUSP3 deletion lead to 540 
decreased activation of the ERK1/2 and Akt signalling molecules under the control of 541 
oestrogen. Decreased phosphorylation of these kinases clearly suggests that they are not 542 
directly targeted by DUSP3. The observed decreased phosphorylation could be due to reduced 543 
activation of specific ERK1/2 and PI3K/Akt yet unknown phosphatase. Indeed, preliminary 544 
data from our laboratory show that pervanadate (non-specific protein tyrosine phosphatases 545 
inhibitor) treatment of LPS-stimulated peritoneal macrophages restores ERK1/2 546 
phosphorylation while okadaic acid (inhibitor of Ser/Thr PP1/PP2A), at low and high 547 
concentrations, did not (data not shown). Further investigations using, among others, 548 
phosphoproteomic approaches are required to confirm this hypothesis and identify the specific 549 
substrate(s) for DUSP3 and assess the exact role of this phosphatase in TLR4 signalling under 550 
the influence of female sex hormones. 551 
In summary, we identified DUSP3 dual-specificity phosphatase as a new key signalling 552 
molecule playing an important role in macrophage alternative activation and sexual 553 
dimorphism in innate immune response to infection. Our data suggest that DUSP3 inhibition, 554 
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Figure legends 709 
 710 
Figure 1: Female sex hormones and myeloid cells are required for DUSP3 deletion-induced 711 
resistance to endotoxemia and septic shock. (A) DUSP3+/+ male (n = 12) and female (n = 17), 712 
DUSP3-/- male (n = 13) and female (n = 19) mice were i.p injected with 6 mg/kg of LPS. 713 
Percent survival was assessed twice a day for 10 days. (B) Body temperature of DUSP3+/+ and 714 
DUSP3-/- mice before, 6 h, and 24 h after LPS injection. (C) DUSP3+/+ male (n = 10) and 715 
female (n = 11) and DUSP3-/- male (n = 9) and female (n = 11) mice were subjected to CLP 716 
(one puncture with 21-gauge needle). Survival was documented twice a day for 7 days. (E-G) 717 
DUSP3+/+ and DUSP3-/- were sham operated (n= 9 for DUSP3+/+ and n=8 for DUSP3-/-)  or 718 
OVX (n=9 for DUSP3+/+ and n=11 for DUSP3-/-) 4 weeks after birth. (E) Representative 719 
macroscopic view of uterus after sham surgery or OVX is shown in. (F) 6 weeks after 720 
surgery, mice were i.p injected with 6 mg/kg LPS. Percent survival was assessed twice a day 721 
for 5 days. (G) Body temperature of DUSP3+/+ and DUSP3-/- mice before, 8 h, and 24 h after 722 
LPS injection. (H-K) 10x106 bone marrow cells (BM) from DUSP3-/- C57BL/6-CD45.2 723 
female mice were intravenously injected into lethally irradiated DUSP3+/+ C57BL/6-CD45.1 724 
recipient male and female mice (DUSP3-/- > M-DUSP3+/+ and DUSP3-/- > F-DUSP+/+, 725 
respectively). As control, DUSP3+/+ females BMs were transplanted into lethally irradiated 726 
DUSP3+/+ male or female mice (DUSP3+/+ > M-DUSP3+/+ and DUSP3+/+ > F-DUSP3+/+, 727 
respectively). (H) Representative dot plot of CD45.1 and CD45.2 immune cells in BM 728 
transplanted mice. (I) Percentage of CD45.1 and CD45.2 immune cells in all transplanted 729 
mice. (J) Western blot was performed on peritoneal cells from transplanted mice using anti-730 
DUSP3 antibody. Anti-GAPDH was used as a loading control. Each line corresponds to one 731 
mouse. Line 1: lysate from peritoneal cavity cells of DUSP3+/+ mouse. Lines 2-8: ♀ DUSP3-/- 732 


















     
     
     
     
     
     





after LPS i.p. injection (6mg/mL). Data are presented as mean ± SEM. Survival data were 734 
compared using Kaplan–Meir with log-rank test. *p < 0.05, ***p <0,001, ***p <0,001.  735 
 736 
Figure 2. DUSP3-deletion-induced LPS shock resistance in female mice, but not in male, 737 
OVX and wild type mice, is associated with increased M2-like macrophages in the peritoneal 738 
cavity. (A) Peritoneal cells harvested from PBS and 24h LPS-challenged DUSP3+/+ and 739 
DUSP3-/- mice were analyzed by flow cytometry to evaluate the percentage of T, B, NK, 740 
NKT, neutrophil and macrophage cell populations. For lymphocyte and NK cell phenotyping, 741 
cells were stained using PE-anti-CD3, FITC-anti-CD4, PE-Cy7-anti-B220 and PerCp-Cy5-742 
anti-NK1.1. FSC and SSC were used for gating on live cells and lymphocyte populations. 743 
CD4 T cells were B220neg/NK1.1neg/CD3pos/CD4pos. CD8 T cells were 744 
B220neg/NK1.1neg/CD3pos/CD8pos. B cells were B220pos/NK1.1neg/CD3neg. NK cells were 745 
B220neg/CD3negNK1.1pos and NK-T cells were B220neg/CD3posNK1.1pos. For neutrophils and 746 
macrophages, phenotyping was performed using PerCP-Cy5.5-anti-CD11b, APC-Cy7-anti-747 
Ly6G and APC–anti-F4/80. Neutrophils were F4/80neg/CD11bpos/Ly6Gpos while macrophages 748 
were considered as Ly6Gneg/F4/80pos/CD11bpos. Percentage of the indicated cell population 749 
out of live cells (total live cells for macrophages and neutrophils analysis and leucocytes gate 750 
for the analysis of lymphocytes and neutrophils) are presented as histogram of means (n=3 in 751 
each group) ± SEM. (B) Peritoneal cells from PBS or LPS (24h) injected DUSP3+/+ and 752 
DUSP3-/- male mice, DUSP3+/+ and DUSP3-/- sham operated or OVX female mice were 753 
analysed to discriminate between M1-like macrophages (F4/80intCD11bint) and M2-like 754 
macrophages (F4/80hiCD11bhi). Analysis was performed on Ly6Gneg live cell gate. 755 
Representative dot plot from each group of mice is shown. (C) Quantification of M1-like and 756 
M2-like macrophages out of total live Ly6Gneg cells. Results are presented as means r SEM. 757 


















     
     
     
     
     
     





Nos2 transcripts in harvested peritoneal macrophages of the indicated groups of mice at basal 759 
levels and 24h after LPS injection. The expression of genes of interest was relative to E2M. 760 
n=4 mice in each group. Results are presented as mean r SEM. *p<0.5, **p<0.01. 761 
 762 
Figure 3. DUSP3-KO female mice survival to LPS is not due to a modification in pro-763 
inflammatory cytokines production. Plasma levels of TNF (A), IL-6 (B), IFNJ (C) and IL-10 764 
(D) in DUSP3+/+ and DUSP3-/- male and sham operated or OVX female mice before, at 2h and 765 
at 24h after LPS challenge (6 mg/mL). Cytokine levels were determined using MSD assays. 766 
Results are presented as mean ± SEM. n = 5 mice per group. The same mice were used for all 767 
time points. *p < 0.05, **p < 0.01. 768 
 769 
Figure 4. DUSP3-deficiency affects ERK 1/2 phosphorylation in female mice macrophages 770 
but not in males. Peritoneal macrophages isolated from 12-weeks-old DUSP3+/+ and DUSP3-/- 771 
female, male and OVX mice were stimulated ex vivo with 1 mg/ml LPS for the indicated time 772 
points. (A) Western blots were performed using anti–phospho-ERK1/2 (Thr202/Tyr204) and 773 
anti-ERK1/2 as a loading control. Representative blots are shown for each detected (phospho) 774 
protein. Densitometry quantifications of phosphor-ERK1/2 and ERK1/2 were performed. (B) 775 
Anti–phospho- MEK1/2 (Ser217/221) and anti-MEK1/2, as loading control and densitometry 776 
quantifications of phospho-MEK and MEK. Results are presented as a ratio of phospho-777 
ERK/ERK and phospho-MEK/MEK from four independent experiments. For each 778 
experiment, peritoneal cells from 2-3 individual mice were pooled prior to stimulation with 779 
LPS and lysis. Data are shown as mean ± SEM. *p < 0.05. 780 
 781 
Figure 5. DUSP3-deficiency affects PI3K/Akt pathway in female, but not in male mice 782 


















     
     
     
     
     
     





female, male and OVX mice were stimulated ex vivo with 1 mg/ml LPS for the indicated time 784 
points. (A) Western blots were performed using anti–phospho-PI3K (p85 Tyr 458/ p55 785 
Tyr199), anti-phospho-Akt (Ser473), anti-phospho-GSK3α/β (Ser21/9) and anti-PI3K, anti-786 
Akt and anti-GSK3α/β as loading controls. (B) Densitometry quantifications of phospho-787 
PI3K, phospho-Akt, phospho-GSK3α/β, PI3K, Akt and GSK3α/β. Results are presented as a 788 
ratio of phospho-PI3K/PI3K, phospho-Akt/Akt and phospho-GSK3α/β/GSK3α/β from four 789 
independent experiments. For each experiment, peritoneal cells from 2-3 individual mice were 790 
pooled prior to stimulation with LPS and lysis. Data are shown as mean ± SEM. *p, 0.05. 791 
 792 
Figure 6.  Alteration of ERK1/2 and Akt phosphorylation in DUSP3-/- female macrophages is 793 
oestrogen-depend. Peritoneal macrophages isolated from OVX DUSP3+/+and DUSP3-/- and 794 
from OVX DUSP3+/+and DUSP3-/- under estrogens complementation?(3 weeks, 1.5µg/day) 795 
were stimulated ex vivo with 1 Pg/ml LPS for the indicated time points. (A) Western blots 796 
were performed using anti–phospho-ERK1/2 (Thr202/Tyr204), anti–phospho-PI3K (p85 Tyr 797 
458/ p55 Tyr199), anti-phospho-Akt (Ser473), anti-PI3K, anti-ERK1/2 and anti-Akt as 798 
loading controls. (B) Densitometry quantifications of phospho-ERK, phospho-PI3K, 799 
phospho-Akt, ERK1/2, PI3K and Akt. Results are presented as a ratio of phospho-800 
ERK1/1/ERK1/2, phospho-PI3K/PI3K and phospho-Akt/Akt from 3 independent 801 
experiments. For each experiment, peritoneal cells from 3 individual mice were pooled prior 802 
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